Clinical Trial Update: Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Epirubicin + Cyclophosphamide versus Epirubicin + Paclitaxel in women with metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ELLENCE (Epirubicin hydrochloride)
• Endoxan (Cyclophosphamide)
• Taxol (paclitaxel)

Snippet

Sponsor: Medical Research Council | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED